AACR Congratulates Raymond N. DuBois, MD, PhD, FAACR, on His New Role at The Mark Foundation for Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Raymond N. DuBois, MD, PhD, FAACR, on his...
Search/Filter
Loading...
AACR Releases Report Outlining Impact of COVID-19 Pandemic on Cancer Research and Patient Care
PHILADELPHIA – Today, the American Association for Cancer Research (AACR) released the AACR Report on the Impact of COVID-19...
AACR Statement on President Biden’s New Cancer Moonshot Announcement
WASHINGTON, DC – Today, American Association for Cancer Research (AACR) CEO Margaret Foti, PhD, MD (hc), issued the following...
Rural Residents Tend to Hold Fatalistic Beliefs and Perceive More Cancer-related Information Overload Than Urban Residents
PHILADELPHIA – Compared to U.S. urban adults, rural adults were more likely to think fatalistically about cancer and feel...
Younger Individuals May Have the Highest Risk of Presenting with Distant-stage Colorectal Cancer
Risk may be greatest among young Black and Hispanic subgroups PHILADELPHIA – Individuals between 20 and 39 years old...
Combination Therapies May Improve Outcomes Due to Independent, Rather Than Synergistic or Additive, Drug Action
Findings have implications for future cancer clinical trial design involving immune checkpoint inhibitors PHILADELPHIA – Independent drug action, not...
Survival Rate of Adult Patients With Relapsed Acute Lymphoblastic Leukemia After Hematopoietic Cell Transplantation Has Steadily Increased Over the Past Two Decades
Study reports progressive improvement in the outcomes of patients carrying the Philadelphia chromosome PHILADELPHIA – For patients with acute...
The Inaugural WHO Classification of Childhood Tumors Will Provide a Unified, Updated Resource for the Diagnosis of Pediatric Cancers
Resource reflects transition from a mostly microscopy-driven to a molecularly driven classification system PHILADELPHIA – The first classification of...
Investigational Therapy Pyrotinib with Chemotherapy May Improve Outcomes in Patients with Pretreated HER2-positive Breast Cancer
SAN ANTONIO – Among patients with previously treated HER2-positive metastatic breast cancer, those who received pyrotinib plus capecitabine had...
Breast Cancer Patients with Estrogen Receptor Mutations May Benefit From Early Switch to Fulvestrant/Palbociclib
Mutations were detected via circulating tumor DNA before disease progression in patients treated with an aromatase inhibitor/palbociclib for hormone...